Related Experiment Videos
Evaluation of recurrent thrombosis and hypercoagulability
1Baptist Regional Cancer Center, Jacksonville, Florida, USA.
American Family Physician
|November 14, 1997
Summary
Inherited coagulation disorders, like activated protein C resistance, are increasingly recognized. Early testing by primary care physicians is crucial for timely management with anticoagulants like warfarin.
Area of Science:
- Hematology
- Medical Genetics
Background:
- Coagulation mechanisms were established over a century ago.
- Inherited coagulation disorders have gained recognition in recent decades.
- Hypercoagulability is often linked to activated protein C resistance and other protein defects.
Purpose of the Study:
- To highlight the importance of recognizing and diagnosing inherited coagulation disorders.
- To guide primary care physicians on initiating diagnostic testing for hypercoagulability.
- To inform optimal timing for genetic testing relative to anticoagulant therapy.
Main Methods:
- Review of established knowledge on coagulation mechanisms.
- Discussion of diagnostic approaches for inherited thrombophilia.
- Outline of management strategies for hypercoagulable states.
Main Results:
- Activated protein C resistance is a significant cause of hypercoagulability.
- Primary care physicians can play a key role in early detection.
- Testing should precede anticoagulant treatment initiation.
Conclusions:
- Early identification of inherited coagulation disorders is essential.
- Appropriate diagnostic testing aids in effective patient management.
- Anticoagulant therapy, often involving warfarin and heparin, is a common management approach.